Vericel (VCEL) Assets Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.38% |
| Dec 31, 2025 | 12.77% |
| Sep 30, 2025 | 16.10% |
| Jun 30, 2025 | 15.60% |
| Mar 31, 2025 | 19.04% |
| Dec 31, 2024 | 22.36% |
| Sep 30, 2024 | 22.72% |
| Jun 30, 2024 | 21.28% |
| Mar 31, 2024 | 34.54% |
| Dec 31, 2023 | 29.54% |
| Sep 30, 2023 | 28.27% |
| Jun 30, 2023 | 26.92% |
| Mar 31, 2023 | 10.32% |
| Dec 31, 2022 | 12.02% |
| Sep 30, 2022 | 10.65% |
| Jun 30, 2022 | 10.30% |
| Mar 31, 2022 | 13.63% |
| Dec 31, 2021 | 18.53% |
| Sep 30, 2021 | 42.31% |
| Jun 30, 2021 | 51.30% |
| Mar 31, 2021 | 40.73% |
| Dec 31, 2020 | 34.18% |
| Sep 30, 2020 | 14.53% |
| Jun 30, 2020 | 16.58% |
| Mar 31, 2020 | 6.40% |
| Dec 31, 2019 | 29.11% |
| Sep 30, 2019 | 10.50% |
| Jun 30, 2019 | 2.97% |
| Mar 31, 2019 | 169.47% |
| Dec 31, 2018 | 117.47% |
| Sep 30, 2018 | 209.01% |
| Jun 30, 2018 | 234.46% |
| Mar 31, 2018 | 29.12% |
| Dec 31, 2017 | 12.30% |
| Sep 30, 2017 | 43.74% |
| Jun 30, 2017 | 24.12% |
| Mar 31, 2017 | 22.78% |
| Dec 31, 2016 | 41.65% |
| Sep 30, 2016 | -21.77% |
| Jun 30, 2016 | -28.59% |
| Mar 31, 2016 | -25.70% |
| Dec 31, 2015 | -27.89% |
| Sep 30, 2015 | -28.91% |
| Jun 30, 2015 | 107.80% |
| Mar 31, 2015 | 350.42% |
| Dec 31, 2014 | 416.32% |
| Sep 30, 2014 | 312.89% |
| Jun 30, 2014 | 249.04% |
| Mar 31, 2014 | -6.65% |
| Dec 31, 2013 | -39.29% |
| Sep 30, 2013 | -46.27% |
| Jun 30, 2013 | -81.33% |
| Mar 31, 2013 | -72.63% |
| Dec 31, 2012 | 96.12% |
| Sep 30, 2012 | 61.37% |
| Jun 30, 2012 | 49.92% |
| Dec 31, 2011 | -76.42% |